NCT00807885 - Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Dehydration

Interventions

DRUG

hylenex-facilitated subcutaneous Lactated Ringer's infusion

single subcutaneous 150 U dose of hylenex, followed by subcutaneous infusion of 1000 mL Lactated Ringer's solution

Trial Locations (2)

MDS Pharma Services, Lincoln

MDS Pharma Services, Neptune City